文献速递静脉血栓栓塞

IL-1β信号、肥胖与静脉血栓栓塞:孟德尔随机化研究

IL-1β Signaling, Obesity, and Venous Thromboembolism: A Mendelian Randomization Study.
PubMed 文献 · Ann Vasc Surg · 2026-03-06

本研究采用双样本及两步孟德尔随机化方法,探讨IL-1β信号、肥胖相关性状与静脉血栓栓塞(VTE)的因果关系及肥胖的中介效应。结果显示,IL-1β信号降低与肺栓塞(PE)风险降低相关(OR=0.06,95%CI 0.01-0.33,P=0.001),且BMI介导了该效应的一部分(中介比例2.78%,95%CI 0.46%-5.10%)。

要点

  • IL-1β信号降低与PE风险降低显著相关。
  • BMI部分介导了IL-1β信号对PE的影响,中介比例约2.78%。
  • 研究为VTE的抗炎治疗提供了遗传学证据支持。

核心结论

  • 降低IL-1β信号与肺栓塞风险降低相关,BMI可能介导此效应,为VTE抗炎治疗提供数据支持。

研究设计与样本

  • 采用双样本和两步孟德尔随机化,研究IL-1β信号、肥胖相关性状(BMI、腰围、腰臀比)与VTE(深静脉血栓、肺栓塞)的关系及肥胖的中介效应。

主要发现

  • IL-1β信号降低与PE风险降低相关(OR=0.06,95%CI 0.01-0.33,P=0.001)。
  • 在3项肥胖相关性状中,BMI与IL-1β信号和PE相关。
  • IL-1β通路对PE的效应由BMI介导(0.92 [0.91, 0.94],P=0.018),中介比例估计为2.78%(95%CI 0.46%-5.10%)。

临床怎么用

  • 提示抗炎治疗(尤其是靶向IL-1β通路)可能成为VTE的潜在治疗策略,但需进一步研究验证。

局限性

  • IL-1β信号、BMI与PE之间的关联需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anticoagulation is standard treatment for venous thromboembolism (VTE) but increases the risk of bleeding. Anti-inflammatory treatment has been shown to be effective in thrombosis. However, research on the potential of anti-inflammatory targets and the interleukin-1 beta (IL-1β) pathway for VTE is lacking. Obesity is accompanied by low-grade chronic inflammation, which increases the risk of VTE. We aimed to investigate the causal relationship between IL-1β signaling, obesity, and VTE. METHODS: We performed a two-sample and two-step Mendelian randomization to investigate the relationship between IL-1β signaling, obesity-related traits (body mass index [BMI], waist circumference, and waist-to-hip ratio), and VTE (deep vein thrombosis, pulmonary embolism [PE]) and the mediating effect of obesity. Genetic instruments for IL-1β signaling were identified as genetic variants, which were both associated with the expression of the IL-1β gene and neutrophil count. RESULTS: Decreased IL-1β signaling was associated with reduced risk of PE (odds ratio = 0.06 [95% confidence interval (CI) 0.01, 0.33], P = 0.001). Among 3 obesity-related traits, BMI was associated with IL-1β signaling and PE. A significant effect of the IL-1β pathway on PE, mediated by BMI, was documented (0.92 [0.91, 0.94], P = 0.018), with an estimated proportion of 2.78% (95% CI [0.46%, 5.10%]) of the total effect. CONCLUSION: The study supported an association between decreased IL-1β signaling and reduced risk of PE. BMI appeared to mediate this effect. The result provides supporting data for potential anti-inflammatory treatment in VTE. The associations between IL-1β signaling, BMI, and PE need further investigation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sun B, Gao L, Wang G, et al. IL-1β Signaling, Obesity, and Venous Thromboembolism: A Mendelian Randomization Study. Ann Vasc Surg. 2026. PMID: 41794124. doi:10.1016/j.avsg.2026.02.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。